DOTA-based complexes of gadolinium (Gd) bearing a thiol moiety on a propyl or hexyl arm were synthesized. It was hypothesized that these complexes would form reversible covalent linkages with human serum albumin (HSA), which contains a reactive thiol at cysteine-34. The binding constant of the hexyl complex to HSA was measured to be 64 mM ؊1 and decreased to 17, 6.1, and 3.6 mM ؊1 in the presence of 0.5, 1, and 2 mM homocysteine, respectively. The binding constant of the propyl complex to HSA was significantly lower (5.0 mM ؊1 ) and decreased to 2.0, 1.5, and 0.87 mM ؊1 in the presence of 0.5, 1, and 2 mM homocysteine, respectively. The longitudinal water-proton relaxivities of the hexyl and propyl complexes at 37°C and 4.7 T were 2.3 and 2.9 mM ؊1 s ؊1 , respectively, in saline. The relaxivities of the HSA-bound forms of the hexyl and propyl complexes were calculated to be 5.3 and 4.5 mM 
Solid tumors are characterized by low pH, hypoxia, and a chaotic and leaky vasculature. In general, these characteristics of tumors are associated with adverse clinical outcomes, resistance to radio-and chemotherapy, likelihood of tumor recurrence and metastases, and shorter patient survival (1) (2) (3) . Recent evidence points to the increased production of antioxidants by cells in hypoxic regions (4) . Electron paramagnetic resonance (EPR) has shown that hypoxic regions in xenograft tumors are indeed highly reducing (5) (6) (7) . The thiol/disulfide redox status of the extracellular milieu is correlated with tumor radiosensitivity (8) and sensitivity to platinum-based anticancer drugs (9 -10) . Emerging evidence also indicates that a reducing extracellular microenvironment aids tumor cell survival and proliferation (11) (12) (13) (14) . Several drugs have been designed to target tumor cells in such hypoxic-reducing microenvironments (15) (16) (17) (18) . Methods for imaging tumor redox status would allow the noninvasive assessment of this potential biomarker of tumor sensitivity to existing and novel platinum-based and redox-active therapies, as well as radiotherapy. The utility of such methods could also extend to other pathologies, such as cardiovascular disease, since free radical formation is associated with deleterious effects on the coronary microcirculation during recovery from myocardial infarction (19) .
The protected Cys 34 site in human serum albumin (HSA) binds thiols as well as other small molecules and metal ions (20) . Tamemasa et al. (21) and Takeda et al. (22) studied the mechanism of transport of the radiological imaging agent 99m Tc coupled to homocysteine and cysteine, which they found to accumulate in experimental tumors. A large fraction of injected 99m Tc-Homocysteine was albumin-bound, indicating that 99m Tc-Homocysteine spontaneously bound to plasma albumin in vivo (21) . 99m Tc-Homocysteine was found to bind only mercaptalbumin, and not nonmercaptalbumin (23) , suggesting an essential role for the Cys 34 residue (24) . They also found that injecting reduced glutathione (GSH), homocysteine, or cysteine intravenously into an animal that was predosed with 99m Tc-homocysteine sharply decreased the vascular retention time of the radionuclide. In vitro analyses showed that this was due to conversion of albumin from the mercapto to the nonmercapto form (23) .
We synthesized DO3A-based thiol complexes of gadolinium (Gd) that were designed to exploit this redox-sensitive binding site on albumin. We present in vitro evidence of reversible redox-sensitive binding of two such complexes to HSA. We also present in vivo evidence of spontaneous binding of these complexes to circulating plasma albumin in mice. The potential for the use of such Gd complexes as redox-sensitive or blood-pool contrast agents for MRI is discussed.
MATERIALS AND METHODS
Synthesis of Gd-DO3A-NH-(CH 2 ) n -SH, n ϭ 3 and 6
Two representatives of the family of HSA-binding thiols with the general structure shown in Fig. 1 , where n ϭ 3 and 6, were synthesized as depicted in Fig. 2 and as described in the following protocol.
Synthesis of Tritylthiopropylphthalimide (3a)
Trityl mercaptan (6.52 g, 23 mmol) was added to a suspension of NaH (0.624 g, 26 mmol) in dry DMF (20 mL) in three portions with cooling under an argon atmosphere. After 0.5 hr a solution of 3-bromopropylphthalimide (2a) (7.0 g, 26 mmol) in DMF (20 mL) was added dropwise to the reaction mixture, which was then stirred for 5 min with cooling and then at room temperature overnight. A mixture of 200 mL of petroleum ether/ether (4:1) was added to the reaction mixture to precipitate NaBr. The precipitate was removed by filtration and the filtrate was evaporated to dryness under vacuum. The residue was titurated with petroleum ether to obtain 9.5 g of 3a (20 mmol 
Synthesis of Tritylthiopropylamine (4a)
To a suspension of 3a (6.0 g, 12.95 mmol) in absolute EtOH (75 mL) was added 98.5% hydrazine (1.03 g, 32.4 mmol), and the mixture was heated at 45°C for 0.5 hr. The resulting solid was removed by filtration and the filtrate was evaporated to dryness under reduced pressure. Chloroform (100 mL) was added to the residue, and the mixture was stirred for 0.5 hr and then filtered. The precipitate was washed with CHCl 3 (100 mL) and the combined organic fractions were washed with water (3 ϫ 100 mL), dried (Na 2 SO 4 ), filtered, and concentrated. Flash chromatography (CHCl 3 /benzene/EtOH/aq NH 4 OH (4:2:1:0.1)) yielded 3.91 g (11.74 mmol, 85%) of 4a as a white solid, mp 48 -50°C. 1 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA, 6.4 H 2 O) (1.248 g, 2.4 mmol) was dissolved in water (3 mL), lyophilized, and dissolved in DMF/TEA (4:1, v/v, 120 mL) and stirred at room temperature for 24 hr. Isobutyl chloroformate (164 mg, 1.2 mmol) was added to the reaction mixture at 0°C. After 1 hr tritylthiopropylamine (4a) (267 mg, 0.8 mmol) was added and the reaction mixture was stirred. After 48 hr the solvent was removed under reduced pressure and the crude solid was loaded onto a flash silica gel column. Elution with CHCl 3 / MeOH/aq NH 4 OH (5:3:0.3) followed by removal of solvents gave 5a as a semisolid, which was dissolved in a minimal amount of water and freeze-dried. By this procedure 5a (495 mg, 0.687 mmol) was obtained as a white fluffy solid in 86% yield. 1 Binding of Gd-DO3A-NH-(CH 2 ) n -SH to HSA Solutions of Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH were made in phosphate-buffered saline (PBS), PBS containing 0-2 mM homocysteine (Sigma), PBS containing 0.66 mM HSA (Sigma), and PBS containing 0.66 mM HSA and 0 -2 mM homocysteine, to final Gd concentrations (Gd Total ) of 0 -1.0 mM. All solutions also contained 10 mM sodium azide to inhibit microbial growth, and the final pH of all solutions was 7.35-7.40 at room temperature. The solutions were allowed to equilibrate overnight at 37°C prior to measurements. Then 500-L aliquots of each solution containing HSA were placed in prewarmed ultrafiltration units (Amicon UItra-4 centrifugal filter units, 30000 MW cutoff; Millipore Corp.) and immediately centrifuged at 3000 g for 5 min, inclusive of braking time. It was assumed that Gd bound to HSA would not pass through the membrane, and that the filtrate accurately represented the unbound Gd (Gd free ) in each sample (25) . The Gd concentration in the filtrates was determined by inductively coupled plasma mass spectrometry. The apparent equilibrium binding constant (K) for each complex was calculated from the law of mass action, assuming a single binding site:
where GdS represents free Gd, and GdS ⅐ HSA represents bound Gd. The above reaction scheme is approximate, and several concurrent stoichiometries are likely, since the Gd complex can be in either monomer or dimer form, and the Cys 34 of the HSA obtained from Sigma can be either in reduced form or in disulfide linkage with an endogenous thiol, such as cysteine or homocysteine.
Relaxivity of Gd-DO3A-NH-(CH 2 ) n -SH in PBS
Measurements of the longitudinal water-proton relaxivities of Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH in PBS were made at 37°C on a 4.7 T Bruker Biospec MR instrument (Bruker Biospin, Billerica, MA). We cut down 96-well tissue culture plates (Falcon) to 6 ϫ 9 wells, creating a sample tray that fit inside a 72-mm-ID birdcage radiofrequency (RF) transmitter-receiver coil (Bruker). Aliquots (200 L) of the Gd solutions were loaded into these wells. Spaces between the wells were filled with PBS so as to reduce air-water susceptibility artifacts in the images. The sample tray was maintained at 37°C during imaging by flowing heated air over the sample tray. Sample temperature was continuously monitored using a fluoroptic temperature probe (Luxtron Corp., Santa Clara, CA, USA). Spin-echo MR images of cross-sections of the wells were acquired with recycle times (TR) ranging between 50 and 8000 ms, and an echo time (TE) of 6 ms. The signal intensity S in each well was fitted to Eq. [3] to extract the T 1 at each solution condition. The factor c was 0.98 -1.0 in all regressions:
The T 1 relaxation times of the solutions of Gd in PBS containing 0 -2 mM homocysteine thus calculated were then fit to Eq. [4] , and a longitudinal relaxivity r 1 was obtained for each solution condition:
where 1/T 10 is the relaxation rate in the absence of contrast agent, and [Gd] is the concentration of Gd in the solution.
Relaxivity of Gd-DO3A-NH-(CH 2 ) n -SH in the Presence of HSA
The relaxivity of Gd in HSA-containing solutions was approximated to have only two components: "free" (monomer, homodimer, and heterodimer), and "bound" (to HSA). The T 1 times of the solutions of both Gd complexes in PBS ϩ HSA were inserted into Eq. [5] and fitted for the relaxivity of bound Gd (r 1,bound ):
where Gd free was obtained by solving Eq. [2] for each solution condition, with K constrained to equal the binding constant calculated for the respective HSA-containing solution. In these regressions, r 1,free was constrained to equal the relaxivity measured in the corresponding HSAfree solution.
Animals for MRI
All of the animal experiments described in this report were conducted in accordance with the policies of the Institutional Animal Care and Use Committee (IACUC) of the University of Arizona. The kinetics of MR image enhancement and washout of the n ϭ 3 and n ϭ 6 complexes were examined in mice. In addition, the influence of a bolus of homocysteine on the washout kinetics of these thiol complexes of Gd was also examined. Female and male ICR mice were prepared for MRI according to a previously published protocol (26) . Briefly, the mice were anesthetized by inhaled isoflurane (1.5% in O 2 ) and cannulated at the tail vein. The tail-vein cannula consisted of a 30G half-inch stainless steel needle attached directly to one end of PE-20 tubing, with a heparinized septum and luer-lock at the other end. This assembly was constructed to have a low dead volume of Ϸ0.04 mL. A pressuretransducer balloon taped to the animal's chest was used to continuously monitor its respiration rate. The body temperature of the animal was continuously monitored using a rectal fluoroptic temperature probe (Luxtron), and maintained by flowing heated air over the animal. The animal was gently secured in a plastic holder and the entire assembly was loaded into a 25-mm-ID small-animal imaging Litz coil (Doty Scientific, Columbia, SC, USA). The coil was centered inside the 4.7 T magnet equipped with 20 G/cm self-shielded gradients for imaging.
In Vivo Contrast-Enhanced (CE)-MRI
Gadolinium complexes for in vivo use were prepared as 25-50-mM solutions in PBS, filter-sterilized, and stored at 4°C prior to use. At the time of injection into the animal, the complexes could therefore have been in a monomer, homodimer, or mixed state. The homocysteine was prepared as a 1 M solution in ultrapure water, adjusted to neutral pH, filter-sterilized, and stored at room temperature. MRI images of axial slices through the kidneys and surrounding tissues of the mouse were acquired using a fat-suppressed radial spin-echo sequence, collecting 256 points per radial line and 256 lines per 2 radians. This sequence was chosen for both the motion compensation provided by a radial sequence, and the high temporal resolution made possible by sliding-window reconstruction of the radial data (see below). Precontrast images were acquired with TE ϭ 9 ms, and TR ϭ 3000 ms and 500 ms. For the dynamic portion of the experiment, radial lines were continuously collected with TE ϭ 9 ms and TR ϭ 100 ms. Radial lines collected adjacent in time were separated by approximately 0.78 radians; therefore, a coarse sampling of the full 2 radians of Fourier space was carried out every 800 ms, and complete sampling was carried out every 26 s. After 8.5 min of precontrast data had been collected, the Gd solution was manually administered via the tail-vein cannula at a dose of 0.025-0.1 mmole/Kg, chased with 0.2 mL saline. After 30 min of continuous imaging the mice were administered either 0.25 mL of saline or 1 mmole/Kg of homocysteine chased with 0.2 mL saline. The total injection time for each was 90 s, to minimize both trauma to the tail vein and the impact of a relatively large fluid load being delivered to the animals in a 60-min period. Imaging was performed continuously through both injections. Images were reconstructed offline by filtered back-projection using a sliding window reconstruction (256 radial lines within each window), and an effective temporal resolution of 6.4 s per image was obtained. T 1 maps were computed by fitting precontrast images to Eq. [3] with the factor c fixed at unity.
Arterial Input Function (AIF)
The AIF was approximated by a "vascular normalization function" (VNF) calculated from pixels within a handdrawn region of interest (ROI) that enhanced at least threefold and reached maximum enhancement within 90 s of the start of the injection, analogously to the method of Rijpkema et al. (27) . Signal enhancement produced by GdDTPA was converted to concentration of Gd using Eq.
[4] and a previously measured longitudinal relaxivity of 3.1 mM -1 s -1 at 37°C and 4.7 T in PBS (26) . Signal enhancement produced by Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH was converted to the concentration of Gd using Eqs. [2] and [5] , the appropriate measured values of r 1,free , r 1,bound , and K, an assumed longitudinal relaxation time of 1.5 s for whole blood (28) , and an assumed plasma concentration of albumin of 0.66 mM (24, 29) .
Pharmacokinetic Modeling of DCE-MRI Data
Data were analyzed on a pixel-by-pixel basis using the extended Tofts model (30):
where C k is the time-dependent volume-averaged concentration of Gd calculated as described above, and C p is the AIF. In this model, v e corresponds to the extracellular extravascular volume fraction, v p corresponds to the extracellular vascular volume fraction, and K GF is the volume transfer constant. In the renal cortex, K GF corresponds to the glomerular filtration rate (GFR) per unit tissue volume. Model fitting to Eq. [6] was performed on a pixel-by-pixel basis using programs written in Interactive Data Language (IDL; Research Systems Inc., Boulder, CO).
RESULTS
Binding of Gd-DO3A-NH-(CH 2 ) n -SH to HSA Figure 3a depicts the variation of the bound fraction of Gd with total Gd concentration for Gd-DO3A-NH-(CH 2 ) 3 -SH in PBS ϩ 0.66 mM HSA in the presence of varying concentrations of homocysteine. These data were fitted to Eq.
[2] to extract the apparent binding constant, K. Gd-DO3A-NH-(CH 2 ) 3 -SH binds HSA with modest affinity, and the binding affinity decreases with increasing concentration of homocysteine (Table 1) . Homocysteine is known to bind HSA at Cys 34 (24, 29) , and the data in Fig. 3a indicate competitive binding of Gd-DO3A-NH-(CH 2 ) 3 -SH and homocysteine to the same site. Gd-DO3A-NH-(CH 2 ) 6 -SH binds HSA with greater affinity (Fig. 3b) , and the binding constant similarly decreases with increasing concentration of homocysteine (Table 1 ). The data in Fig. 3b suggest competitive binding of Gd-DO3A-NH-(CH 2 ) 6 -SH and homocysteine to the Cys 34 of HSA.
Relaxivity of Gd-DO3A-NH-(CH 2 ) n -SH Figure 4a depicts the increase in longitudinal relaxation rate produced by increasing concentrations of Gd-DO3A-NH-(CH 2 ) 3 -SH in PBS. These data were fit to Eq. [4] to extract the longitudinal relaxivity of Gd-DO3A-NH-(CH 2 ) 3 -SH in the absence of HSA (r 1,free ). The relaxivities in PBS with 0.0, 0.5, 1, and 2 mM homocysteine were statistically indistinguishable, and these data were therefore combined and are shown in Fig. 4a as a single plot. In addition, Fig. 4a also depicts the variation in relaxation rate produced by Gd-DO3A-NH-(CH 2 ) 3 -SH in the presence of 0.66 mM HSA and varying concentrations of homocysteine. The latter four pairs of data were fit to Eq. [5] , with Gd free obtained by solving Eq. [2] for each solution condition (Fig. 3a) , with r 1,free constrained to equal the value obtained in PBS (Fig. 4a , Table 1 ), and with K constrained to equal the binding constant calculated for the respective HSA-containing solution (Fig. 3a , Table 1 ). The calculated longitudinal relaxivities of HSA-bound Gd-DO3A-NH-(CH 2 ) 3 -SH (r 1,bound ) were, as expected, similar at all four homocysteine concentrations ( Table 1 ). The relative increase in relaxivity of Gd-DO3A-NH-(CH 2 ) 3 -SH upon binding to HSA (r 1,bound vs. r 1,free ) was significant, suggesting some restriction of the reorientational freedom of bound Gd. However, both the absolute and relative increases in relaxivity were low compared to increases reported for other albumin-binding complexes (25, (31) (32) (33) , possibly due to the high flexibility of the acyl linker. Figure 4b depicts the relaxation enhancement produced by Gd-DO3A-NH-(CH 2 ) 6 -SH in PBS, and in PBS with 0.66 mM HSA and varying concentrations of homocysteine. The relaxivities of Gd-DO3A-NH-(CH 2 ) 6 -SH in the absence (r 1,free ) and presence (r 1,bound ) of HSA were calculated by fitting to Eqs. [4] and [5] , respectively, as in Fig.  4a . The relaxivities in PBS with 0.0, 0.5, 1, and 2 mM homocysteine were statistically indistinguishable, and these data were therefore combined into a single plot in Fig. 4b . The calculated longitudinal relaxivities of HSAbound Gd-DO3A-NH-(CH 2 ) 6 -SH (r 1,bound ) were also similar at all four homocysteine concentrations ( Table 1) . As with the n ϭ 3 complex, the fractional increase in relaxivity of Gd-DO3A-NH-(CH 2 ) 6 -SH upon binding to HSA (r 1,bound vs. r 1,free ) was significant, but both the relative and absolute increase in relaxivity were low compared to increases reported for other albumin-binding complexes (25, (31) (32) (33) . This suggests that while there is some degree of restriction of the reorientational freedom of Gd upon binding to HSA, the increase is limited by the high flexibility of the acyl linkers. In addition, changes in the kinetics of water-proton exchange at the Gd upon binding to HSA may also play a role.
In Vivo CE-MRI Figure 5 shows an example T 1 -weighted spin-echo image of an axial slice through the kidneys and nearby tissues in a male ICR mouse. "Vascular" pixels, which were selected automatically as described in Materials and Methods, are depicted in white. In this example it can be seen that both the renal artery and the renal vein have been selected by the algorithm. Because of the slow injections employed, the enhancement kinetics of arteries and veins were not always sufficiently different to make them clearly distinguishable.
Proteins, such as albumin, are excluded from renal glomerular filtration because of their large molecular size. While free Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH are small enough to readily undergo glomerular filtration, it is expected that any complex bound to plasma albumin will not be filtered. Since only filtered Gd is expected to be present in the renal pelvis, we compared renal signal enhancement kinetics in mice following i.v. boluses of Gd-DO3A-NH-(CH 2 ) 3 -SH, Gd-DO3A-NH- The increase in longitudinal relaxation rate produced by increasing concentrations of Gd-DO3A-NH-(CH 2 ) n -SH in PBS was fit to Eq. [4] to yield r 1,free . The relaxation rates in the presence of HSA were fit to Eq. [5] to yield r 1,bound . The fitted relaxivities are listed in Table 1. FIG. 5. T 1 -weighted spin-echo MR image showing an axial crosssection of the kidneys and nearby organs in a male ICR mouse. The "vascular" pixels are indicated in white. It can be seen that our algorithm for automatically identifying vascular pixels selects both the renal artery and the renal vein in this animal.
(CH 2 ) 6 -SH and a control complex, GdDTPA. We also examined the influence on their washout kinetics of chase boluses of saline and homocysteine.
ROIs in the renal cortex and renal pelvis were handdrawn, while the vascular ROI was selected automatically, as shown in Fig. 5 . Signal intensity in the renal cortex following boluses of GdDTPA, Gd-DO3A-NH-(CH 2 ) 3 -SH, and Gd-DO3A-NH-(CH 2 ) 6 -SH, normalized to precontrast intensity, are plotted in Fig. 6a . The vertical gray line indicates the time of injection of the chase bolus of either saline or homocysteine. It can be seen that neither a saline chase nor a homocysteine chase produced a significant change in the slope of the washout curves of any of the complexes. These data also suggest that the washout of Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH is slower than the washout of GdDTPA. The data in Fig. 6a are representative of data from three animals imaged at each pair of contrast agent and chase solution conditions.
Signal enhancements in the renal pelvis of the same animals are shown in Fig. 6b . The absolute values of the five curves were offset on the vertical scale to improve readability. It can be seen that the washout kinetics of GdDTPA were unaffected by the homocysteine bolus. This was also the case when a saline chase bolus was used (not shown). By contrast, the washout curves of both Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH show an upslope immediately following the homocysteine bolus, indicating the arrival of freshly filtered Gd in the renal pelvis. A saline chase of either thiol complex of Gd does not produce this increase. Taken together, these data lend support to the hypothesis that both Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH spontaneously bind circulating albumin upon intravenous injection into mice. The fraction of Gd that is albumin-bound at any time is excluded from glomerular filtration, which prolongs its retention in the blood-pool. Homocysteine in the chase bolus competes for binding to albumin, resulting in the release of free Gd-DO3A-NH-(CH 2 ) 3 -SH or Gd-DO3A-NH-(CH 2 ) 6 -SH, which are then promptly filtered and appear in the renal pelvis. The data in Fig. 6b are representative of data from three animals imaged under each pair of contrast agent and chase solution conditions.
The calculated concentration of Gd in vascular pixels in the same animals is shown in Fig. 7 . For visual clarity, only the VNFs following GdDTPA chased with homocysteine, and Gd-DO3A-NH-(CH 2 ) 6 -SH chased with saline and homocysteine are shown. The washout of Gd-DO3A-NH-(CH 2 ) 6 -SH is shown to be markedly slower than that of GdDTPA. The VNF of GdDTPA was not noticeably affected by a homocysteine chase. The VNF of Gd-DO3A-NH-(CH 2 ) 6 -SH is seemingly unaffected by a bolus of saline. Interestingly, a bolus of homocysteine also does not produce a change in slope of the VNF of Gd-DO3A-NH-(CH 2 ) 6 -SH. Similar results were obtained with Gd-DO3A-NH-(CH 2 ) 3 -SH (not shown). This could be due to other physiological compartments in the body that buffer the plasma concentration of Gd-DO3A-NH-(CH 2 ) 6 -SH, at least on the timescale of our imaging experiment. Detailed biodistribution studies are planned to better elucidate the in vivo pharmacokinetics of both Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH. The data in Fig. 7 are representative of data from three animals imaged under each pair of contrast agent and chase solution conditions. Figures 6 and 7 suggest that the washout of the two thiol complexes of Gd is slower than that of GdDTPA. However, in order to quantify differences in the pharmacokinetics of the various Gd complexes, one must account for the slight differences in injection times, Gd dose, and precontrast T 1 of a given tissue from experiment to experiment. We used the extended Tofts model (30) for that purpose. The prolonged retention of any complex in the plasma would result in the calculation of low K GF values in renal pixels. Absolute values of K GF thus calculated may be affected by imperfect measurement of the AIF, the departure of waterproton exchange rates from the fast-exchange limit, as well as signal loss due to T 2 -shortening in regions of high Gd concentration. Nonetheless, as shown in Fig. 8 , there are interesting relative differences in the K GF maps of kidneys and surrounding tissues in mice administered GdDTPA, Gd-DO3A-NH-(CH 2 ) 3 -SH, and Gd-DO3A-NH-(CH 2 ) 6 -SH. In all of the animals it can be seen that K GF in the renal cortex and medulla is significantly higher than in the renal pelvis or extrarenal tissues. The K GF for filtration of Gd-DTPA is Ն0.6 min -1 in the renal cortex (Fig. 8a) . The K GF for filtration of Gd-DO3A-NH-(CH 2 ) 3 -SH is in the range of 0.3-0.5 min -1 in the renal cortex (Fig. 8b) , while the corresponding figure for filtration of Gd-DO3A-NH-(CH 2 ) 6 -SH in the renal cortex ranges from approximately 0.1 to 0.25 min -1 (Fig. 8c) . The mean renal cortical K GF for Gd-DO3A-NH-(CH 2 ) 3 -SH (0.4 Ϯ 0.16 min -1 , n ϭ 6) and for Gd-DO3A-NH-(CH 2 ) 6 -SH (0.2 Ϯ 0.07 min -1 , n ϭ 6) were both significantly lower than for GdDTPA (1.1 Ϯ 0.28 min -1 , n ϭ 6, P Ͻ 0.05). While the K GF for Gd-DO3A-NH-(CH 2 ) 3 -SH was higher than for Gd-DO3A-NH-(CH 2 ) 6 -SH, the difference did not achieve statistical significance (P ϭ 0.067). A higher K GF in the renal cortex corresponds to higher GFRs. GdDTPA is readily filtered, and this is reflected in the generally high cortical K GF values. The two thiol complexes are retained in plasma to some extent due to binding with albumin, and this is reflected in correspondingly lower cortical K GF values.
DISCUSSION
HSA is a major carrier and depot protein that is known to covalently or noncovalently bind several small molecules. HSA interacts reversibly with a broad spectrum of therapeutic agents, which typically bind to a number of highaffinity sites with association constants in the range of 10 -1000 mM -1 . The protected Cys 34 site in HSA binds thiols as well as other small molecules and metal ions (20) . We have presented in vitro and in vivo evidence that two thiol complexes of Gd (Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH) bind albumin in a redox-sensitive manner. The binding of both complexes to HSA in vitro could be described as a mass action equilibrium. A decrease in binding constant with increasing concentration of homocysteine, a thiol also found endogenously in plasma, indicates competition for binding of Gd-DO3A-NH-(CH 2 ) n -SH and homocysteine to the same site on HSA. The longitudinal relaxivities of both complexes increase upon binding to HSA. In vivo dynamic CE-MRI of mice demonstrates that Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH are retained in the blood-pool longer than GdDTPA. In addition, the washout kinetics of Gd-DO3A-NH-(CH 2 ) 3 -SH and Gd-DO3A-NH-(CH 2 ) 6 -SH are altered by an intravenous chase bolus of homocysteine. This is further evidence that these complexes spontaneously bind plasma albumin in a reversible redox-sensitive manner.
While Gd bound to albumin would behave as a macromolecular contrast agent, reduction of the disulfide bond in reducing microenvironments would free the Gd complex and cause it to distribute as a small molecule. We are working on strategies to exploit the expected differences in the pharmacokinetics of such agents in oxidizing vs. reducing microenvironments to produce redox-sensitive contrast enhancement in MR images. Unambiguous interpretation of image enhancement in terms of redox status would require, among other things, a minimal difference between the relaxivities of albumin-bound and unbound Gd. Acyl linkers were chosen to allow relatively free movement of the Gd, independently of the albumin, and thereby reduce the increases in relaxivity from a slowing of molecular motion upon binding to the macromolecule. As the preliminary results presented here demonstrate, we were partially successful in accomplishing this goal of eliminating relaxivity differences between albumin-bound and free Gd complex.
There have been several recent reports of Gd complexes designed to reversibly bind albumin though noncovalent linkages (25, (31) (32) (33) . The stated objective of those studies was the development of blood-pool MRI contrast agents. The thiol complexes of Gd described in this study also exhibit potential as blood-pool MRI contrast agents. For enhancing the blood-pool, rather than for redox-sensitive MRI, the highest possible increase in relaxivity of the Gd upon binding to albumin is desirable. We are therefore also working on parallel strategies to increase the relaxivity enhancement of such complexes upon binding to albumin.
FIG. 8. Parameter maps of K
GF corresponding to axial images through the kidneys of mice, calculated using Eq. [6] for the excretion of (a) GdDTPA, (b) Gd-DO3A-NH-(CH 2 ) 3 -SH, and (c) Gd-DO3A-NH-(CH 2 ) 6 -SH. The color scale runs from 0 to 0.6 min -1 .
There is evidence in the literature of the presence of hypoxia-related reducing regions in tumors. Tumor vascular permeability measured by DCE-MRI of small-molecule contrast agents is an emerging biomarker of tumor angiogenesis and response to antiangiogenic drugs. These measurements could be made more precise through the use of macromolecular contrast agents (Ref. 18 and references therein). The known correlation of tumor redox, hypoxia, and angiogenesis to poor prognosis in cancer highlights the need for noninvasive methodologies to assess these tumor characteristics. There have been significant advances in recent years in the development of blood-pool (25, (31) (32) (33) (34) and redox-sensitive (35) MRI contrast agents. Thiol complexes of Gd offer the potential for developing both classes of MRI contrast agents via the same synthetic strategy.
